Home Newsletters Immunology of Infectious Disease News MyOwnMed Partners with National Institutes of Health to Identify Long-Term Consequences of...

MyOwnMed Partners with National Institutes of Health to Identify Long-Term Consequences of COVID-19 Infection and Recovery

0
My Own Med, Inc. is playing an important role in support of the new NIH IMPACC (IMmunoPhenotyping Assessment in a COVID-19 Cohort) study.
[My Own Med, Inc. (BusinessWire, Inc.)]
6445218 {6445218:nan} apa 50 1 165841 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version